News

Immunovia Prepares for Q4 Presentation with Exciting Updates

Immunovia Prepares for Q4 Presentation with Exciting Updates

Join Immunovia for an Insightful Q4 Presentation

Immunovia AB is gearing up to present its full year results for 2024, and everyone interested in their progress is encouraged to attend the upcoming webcast scheduled for February. Analysts, investors, and members of the media will have the opportunity to learn about the company's latest developments and advancements in its mission to improve pancreatic cancer diagnostics.

Details of the Webcast Teleconference

The presentation will take place on February 25 at 15:00 CET. Participants will be able to access the webcast via Immunovia's official website. Jeff Borcherding, the CEO and President, alongside Karin Almqvist Liwendahl, the CFO, will walk attendees through the results and innovations the company has made in the field of diagnostics.

How to Join the Presentation

Everyone interested in joining the presentation via phone can do so by calling in a few minutes before it starts. Below are the numbers to use based on your location:

Sweden: +46 (0)8 5051 0031
United Kingdom: +44 (0) 207 107 06 13
United States: +1 (631) 570 56 13

After the Presentation

Following the live presentation, a recording will be made available on the Immunovia website. This is a fantastic option for those who cannot attend the live session or wish to revisit the insights shared.

Contact Information for More Details

For further inquiries, contact Karin Almqvist Liwendahl, CFO, at +46 70 911 56 08. Immunovia is dedicated to creating accessible information for everyone interested in their work and impact in the healthcare space.

The Mission and Vision of Immunovia

Immunovia AB is a pioneering diagnostic company focused on increasing survival rates for pancreatic cancer patients through early detection. The company has developed innovative blood-based tests designed to identify individuals at high risk of developing pancreatic cancer by detecting specific proteins and antibodies.

Immunovia collaborates with healthcare providers, top experts, and patient advocacy groups to ensure that their tests become available for individuals who are at heightened risk of this devastating disease. In doing so, they aim to alter the landscape of pancreatic cancer diagnosis and management.

Market Opportunities and Potential

In the USA, which represents the largest market for detecting pancreatic cancer, Immunovia estimates that approximately 1.8 million individuals could benefit from annual surveillance testing for this disease. This estimate underscores a significant opportunity for the company to expand its reach and impact through its advanced testing methods.

Immunovia's shares are traded under the ticker IMMNOV on Nasdaq Stockholm, reflecting its commitment to transparency and growth within the financial market. Investors and stakeholders are encouraged to stay updated with Immunovia's progress through their website.

Frequently Asked Questions

What is the date and time of the Q4 presentation?

The Q4 presentation will be held on February 25 at 15:00 CET.

Who will be presenting during the webcast?

The presentation will be led by Jeff Borcherding, CEO, and Karin Almqvist Liwendahl, CFO.

How can I access the presentation?

Participants can join the webcast via Immunovia's official website where the presentation and slides will be available.

Will there be a recording of the presentation?

Yes, a recording of the presentation will be available on Immunovia's website after the live session.

What is Immunovia's mission?

Immunovia aims to increase survival rates for pancreatic cancer patients by developing early detection methods through innovative diagnostic tests.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Suiteify Teams Up With Findity for German Launch

Updated Category News Views 85

Striking a Partnership That Makes Sense Today's deal rolls in like thunder on a quiet afternoon. Suiteify, the master of HR and business software in the DACH region, hooks up with Findity to unleash a new game-changer in Germany. They’re cooking up Suiteify Expense & Travel, and if you're in the mid-sized business space, it’s worth a pause to see how these two horses...

Continue Reading
Gen Z, Millennials Lean on AI Amid Fiscal Crunch

Updated Category News Views 84

AI Meets Gen Z and Millennials: A Financial Lifeline? Here's an angle you might not expect: young folks are all in for AI, particularly when it comes to navigating banking services. Picture it—18 to 34-year-olds embracing AI far more openly than their older counterparts. We're talking 60% of them valuing 24/7 availability in AI services compared to just 47% of those...

Continue Reading
Terra-Gen's $950M Lockhart Facility Powers California

Updated Category News Views 28

A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...

Continue Reading
Biozen Slashes BP Measurement Time by 40%, No Sacrifice

Updated Category News Views 41

Biozen's Bold Leap in Blood Pressure Measurement You think blood pressure measurement, you think inconvenience—right? Not so fast. Biozen's got something up their sleeve that's shifting the game. At the latest American Heart Association's Scientific Sessions in Chicago, Biozen's bigwigs whipped out their new tech: the BP2000. This isn't just any update; it's a 40% cut...

Continue Reading
TuyaOpen and Silicon Labs Unite for Low-Power Breakthrough

Updated Category News Views 131

Stepping Into New Territory Silicon Labs and Tuya Smart are shaking hands over a deal that might just create a big splash in the pool of connected devices. We're talking about the marriage between TuyaOpen and Silicon Labs' SiWx917 system-on-chip (SoC) for a powerhouse combination aimed directly at developers. In a world where power efficiency rules, having low-power...

Continue Reading
TNL Mediagene: Strategic Moves Shake Up Asian Market

Updated Category News Views 31

Shake-Ups in the Asian Tech Space Something's stirring in the Asian tech jungle, and it's TNL Mediagene making waves. With a dramatic one-two punch, they're managing a business sell-off and bringing in fresh equity. What does all this mean for the market and investors? Let's dig in. Japanese Business: A Clean Break TNL Mediagene just parted ways with its Japanese...

Continue Reading
Ensurise and WSMT Insurance Merge: What's Next?

Updated Category News Views 73

Ensurise and WSMT Insurance Tie the Knot Ensurise, LLC and WSMT Insurance are merging as of March 31, 2026. These two independent insurance advisory firms are pooling resources to shake up the insurance advisory landscape. You wouldn't know it from the polite PR lingo, but this isn't just another corporate shuffle—it’s a big play in a sector ripe for change. The...

Continue Reading
Dixie Group Gears Up for Q3 Earnings Call Reveal

Updated Category News Views 126

Anticipation Builds for The Dixie Group's Q3 Results Ah, the smell of anticipation in the air—it's earnings season again, folks! For those keeping a keen eye, The Dixie Group, Inc. (OTCQB: DXYN) sets the stage for the big unveil of its 2026 third-quarter results. They're rolling out the red carpet for investors on Thursday, November 12, 2026, at 11:30 a.m. Eastern Time,...

Continue Reading
AIM-T1 Wins at CES 2027, Paving AI in Electronics

Updated Category News Views 64

AIM-T1: A Game-Changer for Electronics Manufacturing You ever wonder how a single gizmo could shake up the entire electronics manufacturing world? Well, A.I.Matics' AIM-T1 has done just that by snagging two coveted CES Innovation Awards for 2027. In the cutthroat arenas of Artificial Intelligence and Construction & Industrial Tech, this platform's getting the spotlight...

Continue Reading
Meijer Team Gives Fuels Midwest Nonprofits: $3M Impact

Updated Category News Views 36

Power to the Team: Meijer Makes Big Moves On any ordinary day, you'd see folks in Grand Rapids, Michigan, bustling about their routines, but today packs a different vibe. Meijer, the retailer that's been around the block a few times, is handing over a serious chunk of change to the tune of $3 million. This ain't just some half-hearted corporate stunt. Nope, this is the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Recent Decline of Major Tech Stocks

Updated Category News Views 267

Market Dynamics Affecting Major Tech Stocks Recently, markets have seen a notable downturn in the tech sector, referred to by some as a "tech wreck". This trend is evident as the S&P 500 has dropped around 2% since earlier in the month. However, many tech stocks have faced even steeper declines, raising concerns among investors and analysts alike. Earlier in the year, we...

Continue Reading
Exploring the Future of Pharma 4.0 Market: A Growth Journey

Updated Category News Views 192

The Rapid Transformation of the Pharma 4.0 Market In recent years, the Pharma 4.0 market has gained significant attention from investors and stakeholders in the pharmaceutical industry. A report highlighted that the global Pharma 4.0 market was valued at USD 12.76 billion in 2024 and is projected to soar to USD 72.58 billion by 2034, achieving a remarkable compound annual...

Continue Reading
Compass Lexecon Takes Top Spot in Economic Consulting Rankings

Updated Category News Views 240

Compass Lexecon Excels in Economic Consulting Rankings FTI Consulting, Inc. (NYSE: FCN) has once again highlighted the strength of its Compass Lexecon division by achieving top recognition on a prominent global economic consulting list. The firm secured the honor as experts from Compass Lexecon were named among the best in the Lexology Index: Competition 2025, showcasing...

Continue Reading
Road2Teach Approved for Special Education Teaching in Indiana

Updated Category News Views 190

Road2Teach Achieves Important Milestone in Indiana RESTON, VA — Road2Teach, an innovative alternative teacher certification preparation program and a subsidiary of Stride, Inc., has been recognized by the Indiana Department of Education as an approved provider for its Special Education Transition to Teaching program. This significant development is essential for...

Continue Reading
SoftBank's Strategic $22.5 Billion Deal with OpenAI Unfolds

Updated Category News Views 834

SoftBank Moves Forward with OpenAI Investment SoftBank Group Corp. (OTC:SFTBF) (OTC:SFTBY) has made a significant step by approving a $22.5 billion payment, which is part of its broader $30 billion investment in OpenAI. This decision was led by the dynamic CEO Sam Altman, showcasing SoftBank's commitment to advancing artificial intelligence technologies. Approval...

Continue Reading